Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
7.34
+0.20 (2.80%)
At close: Sep 26, 2025, 4:00 PM EDT
7.28
-0.06 (-0.81%)
After-hours: Sep 26, 2025, 7:46 PM EDT
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $238.71 million as of September 26, 2025. Its market cap has increased by 98.93% in one year.
Market Cap
238.71M
Enterprise Value
103.39M
1-Year Change
98.93%
Ranking
Category
Stock Price
$7.34
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $238.71M, a decrease of -32.72%. That is a compound annual growth rate of -16.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 238.71M | 64.76% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |